Announcement on the Resignation of Core Technical Personnel

Earlier from Shanghai Fudan Zhangjiang Bio Pharmaceutical

• Announcement on Resignation of Senior Management MembersMay 14
• Report for Q1 2026Apr 30
• Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood ConferenceApr 29
• Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase 1 Clinical Trial of FZ-P001 Sodium for Injection for Visualization of Malignant Lesions during Ovarian Cancer SurgeryApr 10
• Announcement on Requesting the General Meeting to Authorize the Board of Directors to Issue Shares to Specific Objects by Summary ProcedureMar 31

Later from Shanghai Fudan Zhangjiang Bio Pharmaceutical

• Announcement on Convening the 2026 Semi-annual Performance BriefingAug 8
• Semi-annual Report for 2026Aug 15
• Announcement on Shareholding Reduction Plan by Shareholder Holding More Than 5% of the SharesAug 26
• Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug IndustrySep 5
• (688505)"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd."Announcement on Convening the Q3 2026 Performance BriefingOct 22